- Shingrix: Package Insert Prescribing Information MOA
Shingrix package insert prescribing information for healthcare professionals Includes: indications, dosage, adverse reactions and pharmacology
- Shingrix: Uses, Dosage, Side Effects, Warnings - Drugs. com
Shingrix is used to prevent herpes zoster (HZ, shingles) in adults 50 years and older, or in adults 18 years and older who are or will be at increased risk of HZ due to immunodeficiency or immunosuppression caused by a known disease or therapy It is administered as 2 intramuscular doses of 0 5 mL, 2 to 6 months apart
- Shingrix vs Zostavax - Whats the difference between them?
The main difference is that Shingrix is more effective at preventing shingles (herpes zoster virus) than Zostavax (overall: 97 2% vs 51%, respectively) Shingrix, from GSK, is an FDA-approved vaccine to help prevent the occurrence of herpes zoster (shingles) Zostavax, a shingles vaccine made by Merck Co, is no longer available on the U S market In placebo-controlled studies, Shingrix
- US FDA Approves GSK’s Shingrix in a Prefilled Syringe Presentation
London, UK 17 July 2025 -- GSK plc (LSE NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe presentation of Shingrix (GSK’s Recombinant Zoster Vaccine or RZV) for the prevention of shingles (herpes zoster) The new prefilled syringe removes the need to reconstitute separate vials prior to administration, simplifying the vaccine
- Shingrix Dosage Guide - Drugs. com
Detailed dosage guidelines and administration information for Shingrix (zoster vaccine recombinant, adjuvanted) Includes dose adjustments, warnings and precautions
- Zoster Vaccine Recombinant (Monograph) - Drugs. com
Zoster Vaccine Recombinant (Monograph) Brand name: Shingrix Drug class: Vaccines VA class: IM100 Medically reviewed by Drugs com on Nov 17, 2025 Written by ASHP Introduction Uses Dosage Warnings Interactions MOA Introduction Inactivated (recombinant) vaccine Zoster vaccine recombinant contains recombinant varicella zoster virus (VZV) surface glycoprotein E (gE) and an adjuvant (i e , AS01 B
- Shingrix FDA Approval History - Drugs. com
Shingrix FDA Approval History FDA Approved: Yes (First approved October 20, 2017) Brand name: Shingrix Generic name: zoster vaccine recombinant, adjuvanted Dosage form: Injection Company: GlaxoSmithKline Treatment for: Herpes Zoster, Prophylaxis Shingrix (zoster vaccine recombinant, adjuvanted) is a non-live, recombinant subunit vaccine for the prevention of herpes zoster (shingles) Shingrix
- Tdap and Td Vaccines for Adults - What You Need to Know
Care guide for Tdap and Td Vaccines for Adults Includes: possible causes, signs and symptoms, standard treatment options and means of care and support
|